Halbert Hargrove Global Advisors’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$713 Buy
+3
New +$623 ﹤0.01% 480
2025
Q4
Sell
-13
Closed -$2.04K 416
2025
Q3
$2.04K Buy
+13
New +$2.01K ﹤0.01% 558
2025
Q2
Sell
-4
Closed -$552 362
2025
Q1
$552 Buy
+4
New +$510 ﹤0.01% 489
2015
Q3
Sell
-5,308
Closed -$444K 108
2015
Q2
$444K Buy
5,308
+86
+2% +$7.59K 0.11% 101
2015
Q1
$471K Buy
5,222
+2,067
+66% +$178K 0.15% 100
2014
Q4
$255K Sell
3,155
-331
-9% -$26.1K 0.13% 107
2014
Q3
$261K Sell
3,486
-82
-2% -$5.97K 0.07% 110
2014
Q2
$245K Buy
3,568
+10
+0.3% +$681 0.07% 100
2014
Q1
$249K Sell
3,558
-215
-6% -$15K 0.08% 100
2013
Q4
$252K Buy
+3,773
New +$231K 0.08% 107

Other funds holding CAH

Halbert Hargrove Global Advisors's CAH Position: Q2 2026 in Review

Halbert Hargrove Global Advisors opened a new position in Cardinal Health (CAH) in Q2 2026: 3 shares worth $713. The stake represents ﹤0.01% of the portfolio and ranks #480 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in CAH as recently as Q3 2025.

Halbert Hargrove Global Advisors first reported a position in CAH in Q4 2013 and has held it in 10 quarters since. The position peaked at $471K in Q1 2015. 1,498 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Halbert Hargrove Global Advisors held 3 shares of Cardinal Health worth $713 as of Q2 2026.
  • Cardinal Health was a new Halbert Hargrove Global Advisors position in Q2 2026.
  • Cardinal Health made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #480 holding.
  • Halbert Hargrove Global Advisors first reported a position in Cardinal Health in Q4 2013 and has held it in 10 quarters since.
  • Halbert Hargrove Global Advisors's Cardinal Health position peaked at $471K in Q1 2015.
  • 1,498 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.